经循环途径血管内栓塞治疗颅内动脉瘤、动静脉畸形与硬脑膜动静脉瘘的多中心研究
九中心回顾性分析40例经循环途径栓塞患者(34例颅内动脉瘤、3例动静脉畸形、3例硬脑膜动静脉瘘),动脉瘤 Raymond-Roy 分级 I-II 达97%,畸形与瘘均完全闭塞;文献汇总152例动脉瘤,术后93.4%达 Raymond-Roy 分级 I-II,2例(1.3%)术中动脉瘤破裂致死亡。
要点
- 经循环途径最常见指征为目标病变入路角度困难(42.5%)与载瘤动脉闭塞(27.5%)。
- 本组动脉瘤 Raymond-Roy 分级 I-II 达97%,所有动静脉畸形与硬脑膜动静脉瘘完全闭塞。
- 文献汇总152例动脉瘤术后93.4%达 Raymond-Roy 分级 I-II,2例(1.3%)术中破裂死亡。
核心结论
- 经循环途径栓塞治疗颅内动脉瘤、硬脑膜动静脉瘘和动静脉畸形似乎安全有效。
研究设计与样本
- 九中心回顾性研究,纳入40例接受经循环途径栓塞的患者(34例颅内动脉瘤、3例动静脉畸形、3例硬脑膜动静脉瘘)。
- 同时进行文献综述,汇总152例经循环途径治疗的颅内动脉瘤。
- 采用 Raymond-Roy 闭塞分级(RROC)与闭塞程度评价治疗成功,并评估轻微/严重并发症及临床/血管造影结局。
主要发现
- 大多数颅内动脉瘤(22/34,64.7%)为择期治疗,3例动静脉畸形和2例硬脑膜动静脉瘘为破裂表现。
- 颅内动脉瘤 Raymond-Roy 分级 I-II 达97%,所有动静脉畸形和硬脑膜动静脉瘘均完全闭塞。
- 1例患者出现短暂动脉血栓,经静脉替罗非班成功治疗。
- 经循环途径最常见指征为目标病变入路角度困难(42.5%)和载瘤动脉闭塞(27.5%)。
- 文献汇总152例动脉瘤中,最常见部位为基底动脉尖(27%)、小脑后下动脉(25%)和颈内动脉(15.1%);跨越后交通动脉60例(39.5%)、前交通动脉48例(31.6%)、椎动脉37例(24.3%);单纯弹簧圈栓塞22例(14.5%)、支架辅助栓塞67例(44.1%)、球囊辅助栓塞36例(23.7%)、支架辅助+球囊辅助栓塞20例(13.2%)、血流导向装置7例(4.6%);术后142例(93.4%)动脉瘤达 Raymond-Roy 分级 I-II;2例(1.3%)严重并发症导致死亡,均为术中动脉瘤破裂伴大量蛛网膜下腔出血和脑疝;平均血管造影随访11.3个月后,仅6/108例(5.6%)动脉瘤显示瘤腔内充盈/复发。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Unfavorable anatomy can preclude traditional anterograde endovascular interventions. Transcirculation approaches, which consist of primary catheterization of a target artery from the contralateral side or opposite cerebral circulation, can provide alternative pathways for successful treatment of these patients. We aimed to assess the safety, efficacy, and outcomes of endovascular embolization through transcirculation approaches. METHODS: Nine centers provided retrospective data on patients who underwent transcirculation procedures for embolization of intracranial aneurysms (IAs), dural arteriovenous fistulas (dAVFs), and arteriovenous malformations (AVMs). Raymond-Roy Occlusion Classification (RROC) grades and degree of obliteration were used to evaluate treatment success. Minor/major complications and clinical/angiographic outcomes were also assessed. A review of the literature reporting patients who underwent transcirculation embolizations was also performed. RESULTS: Forty patients were included in the study (34 IAs, 3 AVMs, and 3 dAVFs). Most IAs (22/34, 64.7%) were treated electively. Three AVMs and 2 dAVFs presented ruptured. RROC grade I-II was achieved in 97% of IAs. All AVMs and dAVFs were completely obliterated. One patient developed a transient arterial thrombus that was successfully treated with intravenous tirofiban. The most common indications for a transcirculation approach were difficult access angle of the target lesion (42.5%) and occlusion of the parent artery (27.5%). The review of the literature pooled 152 IAs treated via transcirculation approaches. Most common locations were the basilar tip (27%), posterior inferior cerebellar artery (25%), and internal carotid artery (15.1%). The posterior communicating artery was crossed in 60 (39.5%), anterior communicating artery in 48 (31.6%), and vertebral artery in 37 (24.3%) patients. Primary coiling alone was performed in 22 (14.5%), stent-assisted coiling in 67 (44.1%), balloon-assisted coiling in 36 (23.7%), stent-assisted coiling + balloon-assisted coiling in 20 (13.2%) and flow diversion in 7 (4.6%) patients. After intervention, 142 (93.4%) IAs achieved successful RROC grades I-II. Two major complications (1.3%) leading to death were reported, both of which were intraprocedural aneurysmal ruptures with massive subarachnoid hemorrhage and herniation. After a mean angiographic follow-up of 11.3 months, only 6/108 (5.6%) IAs showed intrasaccular filling/recurrence. CONCLUSIONS: Transcirculation approaches seem to be safe and effective in the treatment of IAs, dAVFs, and AVMs. The most common indication for a transcirculation approach is the presence of a difficult angle to access the target lesion and occlusion of the parent artery.
引用
- Roa JA, Ortega-Gutierrez S, Martinez-Galdamez M, et al. Transcirculation Approach for Endovascular Embolization of Intracranial Aneurysms, Arteriovenous Malformations, and Dural Fistulas: A Multicenter Study. World Neurosurg. 2019. PMID: 31759150. doi:10.1016/j.wneu.2019.11.078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。